GILD
Gilead Sciences Inc
Price:  
109.98 
USD
Volume:  
7,606,841.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Gilead EV/EBITDA

-27.9%
Upside

As of 2025-06-16, the EV/EBITDA ratio of Gilead Sciences Inc (GILD) is 8.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Gilead's latest enterprise value is 153,833.42 mil USD. Gilead's TTM EBITDA according to its financial statements is 19,024.00 mil USD. Dividing these 2 quantities gives us the above Gilead EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 9.6x - 11.3x 10.6x
Forward P/E multiples 11.2x - 15.1x 11.4x
Fair Price 9.63 - 159.43 79.25
Upside -91.2% - 45.0% -27.9%
109.98 USD
Stock Price
79.25 USD
Fair Price

Gilead EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-13 8.09
2025-06-12 8.22
2025-06-11 8.04
2025-06-10 8.09
2025-06-09 8.28
2025-06-06 8.25
2025-06-05 8.12
2025-06-04 8.02
2025-06-03 8.04
2025-06-02 8.02
2025-05-30 8.09
2025-05-29 8.16
2025-05-28 7.99
2025-05-27 8.03
2025-05-23 7.92
2025-05-22 7.87
2025-05-21 7.94
2025-05-20 8.03
2025-05-19 7.84
2025-05-16 7.60
2025-05-15 7.46
2025-05-14 7.33
2025-05-13 7.53
2025-05-12 7.68
2025-05-09 7.23
2025-05-08 7.31
2025-05-07 7.36
2025-05-06 7.30
2025-05-05 7.62
2025-05-02 7.67
2025-05-01 7.65
2025-04-30 7.86
2025-04-29 7.71
2025-04-28 7.85
2025-04-25 7.64
2025-04-24 7.84
2025-04-23 7.85
2025-04-22 7.79
2025-04-21 7.72
2025-04-17 7.73
2025-04-16 7.75
2025-04-15 7.81
2025-04-14 7.86
2025-04-11 7.67
2025-04-10 7.53
2025-04-09 7.78
2025-04-08 7.64
2025-04-07 7.79
2025-04-04 7.91
2025-04-03 8.24